Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah M Jones

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
American Journal of Translational Research|July 12, 2016
Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cellsJoshua Kilgore, Amanda L Jackson, Leslie H Clark, et al.
American Journal of Cancer Research|January 10, 2018
Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer <i>in vitro</i>Hannah M Jones, Ziwei Fang, Wenchuan Sun, et al.
American Journal of Cancer Research|June 12, 2018
Erratum: Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer <i>in vitro</i>Hannah M Jones, Ziwei Fang, Wenchuan Sun, et al.
Diabetes Technology & Therapeutics|July 28, 2025
A Pilot Study Evaluating Meal Timing, Macronutrient Composition, and Faster-Acting Insulin Aspart Versus Insulin Aspart on Postprandial Glycemia with the Medtronic Advanced Hybrid Closed-Loop SystemDale J Morrison, Melissa H Lee, Sara Vogrin, et al.
Frontiers in Pharmacology|October 13, 2022
Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumorsWeize Huang, Felix Stader, Phyllis Chan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2012
Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte dataHannah M Jones, Hugh A Barton, Yurong Lai, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 23, 2020
A Physiologically-Based Pharmacokinetic Model for the Prediction of "Half-Life Extension" and "Catch and Release" Monoclonal Antibody PharmacokineticsHannah M Jones, John Tolsma, Zhiwei Zhang, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 11, 2025
PBPK-Led Assessment of Antimalarial Drug Concentrations in Breastmilk: A Strategy for Optimal Use of Prediction Methods to Guide Decision Making in an Understudied PopulationLisa M Almond, Khaled Abduljalil, Amita Pansari, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2012
In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigationYi-An Bi, Emi Kimoto, Samantha Sevidal, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 2011
Application of PBPK modelling in drug discovery and development at PfizerHannah M Jones, Maurice Dickins, Kuresh Youdim, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
American Journal of Translational Research|July 12, 2016
Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cellsJoshua Kilgore, Amanda L Jackson, Leslie H Clark, et al.
American Journal of Cancer Research|January 10, 2018
Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer <i>in vitro</i>Hannah M Jones, Ziwei Fang, Wenchuan Sun, et al.
American Journal of Cancer Research|June 12, 2018
Erratum: Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer <i>in vitro</i>Hannah M Jones, Ziwei Fang, Wenchuan Sun, et al.
Diabetes Technology & Therapeutics|July 28, 2025
A Pilot Study Evaluating Meal Timing, Macronutrient Composition, and Faster-Acting Insulin Aspart Versus Insulin Aspart on Postprandial Glycemia with the Medtronic Advanced Hybrid Closed-Loop SystemDale J Morrison, Melissa H Lee, Sara Vogrin, et al.
Frontiers in Pharmacology|October 13, 2022
Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumorsWeize Huang, Felix Stader, Phyllis Chan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 21, 2012
Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte dataHannah M Jones, Hugh A Barton, Yurong Lai, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 23, 2020
A Physiologically-Based Pharmacokinetic Model for the Prediction of "Half-Life Extension" and "Catch and Release" Monoclonal Antibody PharmacokineticsHannah M Jones, John Tolsma, Zhiwei Zhang, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 11, 2025
PBPK-Led Assessment of Antimalarial Drug Concentrations in Breastmilk: A Strategy for Optimal Use of Prediction Methods to Guide Decision Making in an Understudied PopulationLisa M Almond, Khaled Abduljalil, Amita Pansari, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2012
In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigationYi-An Bi, Emi Kimoto, Samantha Sevidal, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 2011
Application of PBPK modelling in drug discovery and development at PfizerHannah M Jones, Maurice Dickins, Kuresh Youdim, et al.
Pageof 10